Sanofi says US FDA to review diabetes drug lixisenatide
February 19, 2013 at 01:13 AM EST
PARIS, Feb 19 (Reuters) - French drugmaker Sanofi said on Tuesday that its experimental diabetes drug lixisenatide has been accepted for review by the U.S. Food and Drug Administration.
